Cargando…
33886 Deregulation of the LANCL2 Pathway in Alzheimer's Disease
ABSTRACT IMPACT: My work focuses on understanding the role of an immunomodulatory pathway in Alzheimer’s disease as a potential therapeutic target. OBJECTIVES/GOALS: My long-term goal is to develop effective drugs to halt the progression of Alzheimer’s disease (AD). The overall objective of this tra...
Autores principales: | Birnbaumria, Emily, Figueiredo-Pereira, Maria, Rockwell, Patrica, Henchcliffe, Claire, Serrano, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827686/ http://dx.doi.org/10.1017/cts.2021.431 |
Ejemplares similares
-
Apoptosis deregulation in myeloproliferative neoplasms
por: Tognon, Raquel, et al.
Publicado: (2013) -
LanCL proteins are not Involved in Lanthionine Synthesis in Mammals
por: He, Chang, et al.
Publicado: (2017) -
LANCL1 as the Key Immune Marker in Neuropathic Pain
por: Shi, Yu, et al.
Publicado: (2022) -
Identification of Critical Pathways and Hub Genes in LanCL1-Overexpressed Prostate Cancer Cells
por: Tang, Run, et al.
Publicado: (2020) -
First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis
por: Tubau-Juni, Nuria, et al.
Publicado: (2021)